Results 51 to 60 of about 376,422 (297)

Evaluation of the Relationship Between HbA1c with MPV and PDW Levels in Patients with Type-2 Diabetes Mellitus

open access: yesAnkara Medical Journal, 2020
INTRODUCTION: Macrovascular and microvascular complications are major responsible for mortality and morbidity that develop over time in diabetic patients. MPV and PDW levels can be reduced with good glycemic control and thus prevented or delayed vascular
Hacer Dinçoğlu, İrep Karataş Eray
doaj   +1 more source

Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT

open access: yesDiabetes Care
OBJECTIVE To evaluate the cardiovascular effects of semaglutide by baseline glycated hemoglobin (HbA1c) and change in HbA1c in a prespecified analysis of Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT ...
I. Lingvay   +16 more
semanticscholar   +1 more source

A View Beyond HbA1c: Role of Continuous Glucose Monitoring

open access: yesDiabetes Therapy, 2019
Hemoglobin A1C (HbA1c) is used as an index of average blood glucose measurement over a period of months and is a mainstay of blood glucose monitoring. This metric is easy to measure and relatively inexpensive to obtain, and it predicts diabetes-related ...
Haleh Chehrehgosha   +4 more
semanticscholar   +1 more source

Lichen planus and it’s association with diabetes mellitus

open access: yesAsian Journal of Medical Sciences, 2022
Background: Lichen planus(LP) is a unique common inflammatory disorder that is clinically characterized by violaceous pruritic flat polygonal papules or plaques.
Sabina Adhikari , Anupama Karki
doaj   +1 more source

Prognostic Significance of Long-term HbA1c Variability for All-Cause Mortality in the ACCORD Trial

open access: yesDiabetes Care, 2020
OBJECTIVE The association between high glycemic variability and all-cause mortality has been widely investigated in epidemiological studies but rarely validated in glucose-lowering clinical trials.
C. Sheng   +7 more
semanticscholar   +1 more source

Association between performance measures and glycemic control among patients with diabetes in a community-wide primary care cohort [PDF]

open access: yes, 2013
Background: Performance measures are used for assessing quality of care. Higher performance shown by these measures is expected to reflect better care, but little is known whether they predict better patient outcomes.
Denig, P.   +12 more
core   +2 more sources

Prevalence of Microalbuminuria among Rural North Indian Population with Diabetes Mellitus and its Correlation with Glycosylated Haemoglobin and Smoking [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2014
Introduction: Macrovascular and microvascular complications of diabetes mellitus are a consequence of metabolic derangement mainly hyperglycemia. Diabetic nephropathy being one of them causes end stage renal disease.
Juhi Aggarwal, Mayur Kumar
doaj   +1 more source

The relationship between HbA1c reduction and healthcare costs among patients with type 2 diabetes: evidence from a U.S. claims database

open access: yesCurrent Medical Research and Opinion, 2020
Objective To examine the relationship between hemoglobin A1c (HbA1c) reduction and healthcare costs among patients with type 2 diabetes (T2D). Materials and methods Truven MarketScan databases over the time-period from 2013 through 2017 were utilized ...
M. Lage, K. Boye
semanticscholar   +1 more source

Effect of Vitamin D3 Supplementation on the Level of 25(OH)D3, Osteocalcin, and HbA1c in Children with Type 1 Diabetes Mellitus

open access: yesJournal of Tropical Life Science, 2022
Type 1 diabetes mellitus (T1DM) is a chronic disease caused by insulin deficiency resulting from autoimmune destruction of pancreatic beta cells.
Hajeng Wulandari   +2 more
doaj   +1 more source

Heritability of variation in glycaemic response to metformin:a genome-wide complex trait analysis [PDF]

open access: yes, 2014
Background: Metformin is a first-line oral agent used in the treatment of type 2 diabetes, but glycaemic response to this drug is highly variable.
Ahlqvist, Emma,   +49 more
core   +1 more source

Home - About - Disclaimer - Privacy